Recently, Thermo Fisher Technologies, a global leader in enabling scientific and technological progress (hereinafter referred to as: Under the guidance of its newly upgraded development commitment in China – “Creation and co-growth”, Thermo Field has again accelerated the localization process and launched a number of domestic new products covering pharmaceutical and biopharmaceutical, academic research, medical health, industrial and application markets and other vertical fields, in order to continue to improve local research and development, manufacturing and service capabilities to further meet local customer needs.

The 14th Five-Year Plan has raised localization and independent innovation to an unprecedented strategic height. As a global leader in enabling scientific and technological progress, with its innovation gene, Thermo Field integrates cutting-edge technology with local Chinese wisdom, builds a solid local supply chain, produces localized products, develops customized local innovative products, continuously introduces advanced technologies and solutions, and jointly promotes high-quality development in China with local partners.

“Made in China” enables new development of local industries

8421-CC-PS

8421-CC-PS

In recent years, through continuous investment in local research and development and production in China, Thermo field’s localized production capacity has been gradually released, and a series of domestic new products have been launched.

Among them, the Forma Steri-Cycle CO2 incubator produced in Suzhou, China, adopts advanced gas control technology, has efficient HEPA filter and simple high-temperature sterilization function, which can greatly reduce the pollution during culture and provide a stable and uniform cell culture environment. At the same time, the Thermo Scientific STP series of ultra-low temperature refrigerators manufactured in Suzhou are designed to provide a safe and reliable storage environment for precious samples, meeting the needs of environmental friendliness and storing more samples per unit space. Based on Thermo Field’s more than 80 years of cryogenic storage experience, the product provides cryogenic storage solutions for biopharmaceuticals, scientific research institutions, etc., to facilitate the development of local customers’ scientific research.

In addition, in recent years, the field of cell and gene therapy has developed rapidly in China, and the demand for the clinical trial supply chain of ultra-low temperature biological products and CGT products is growing. Thermo Field launched a new clinical trial supply chain solution for CGT products based on local customer needs, which is the first clinical supply chain service in China and the world to guarantee from cell collection to drug delivery. Supported by Thermo Field’s global quality system and many years of global experience, the solution not only integrates a number of new facilities including gas phase liquid nitrogen freezer, ultra-low temperature refrigerator, biosafety cabinet, but also equipped with ultra-low temperature transportation equipment and real-time temperature monitoring system, and the global GMP warehouse as a network support, to protect the entire clinical trial process of local customers.